• Exchange: Frankfurt
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Specialty Pharmaceuticals


13.700 EUR 0.358 2.55%

As of 02:01:32 ET on 07/10/2014.

Snapshot for Zafgen Inc (ZA7)

Open: 13.699 Day's Range: 13.699 - 13.700 Volume: 0
Previous Close: 14.058 52wk Range: 13.699 - 14.692 1-Yr Rtn: -

Stock Chart for ZA7

No chart data available.
  • ZA7:GR 13.699
  • 1D
  • 1M
  • 1Y
Interactive ZA7 Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for ZA7

Current P/E Ratio (ttm) -
Estimated P/E(-) -
Relative P/E vs. DAX -
Earnings Per Share (ttm) -
Est. EPS -
Est. PEG Ratio -
Market Cap (M EUR) 298.76
Shares Outstanding (M) 21.81
30 Day Average Volume -
Price/Book (mrq) -
Price/Sale (ttm) -
Dividend Indicated Gross Yield -%
Cash Dividend -
Dividend Ex-Date
5 Year Dividend Growth -
Next Earnings Announcement -
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for ZA7

No data available

Company Profile & Key Executives for ZA7

Zafgen Inc. operates as a biopharmaceutical company. The Company develops obesity therapeutics for use in the treatment of obesity and associated co-morbidities. Zafgen offers its services worldwide.

Peter BarrettChairmanThomas E HughesChief Executive Officer
Patricia L Allen "Patty"Chief Financial OfficerDennis D KimChief Medical Officer
More Company Profile & Key Executives for ZA7

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Sponsored Links
sec ||= nil